![Drugmaker Deals Are Near Record Pace in 2019, but Investors Don't Love Them All - The New York Times Drugmaker Deals Are Near Record Pace in 2019, but Investors Don't Love Them All - The New York Times](https://static01.nyt.com/images/2019/06/26/business/26db-drugs1/merlin_157004427_c3dc322a-01a3-4b26-8965-00078099cf8d-superJumbo.jpg)
Drugmaker Deals Are Near Record Pace in 2019, but Investors Don't Love Them All - The New York Times
![AbbVie buy shores up immunology business • State board takes up Advocate-Atrium deal Nov. 14 • Abbott's baby formula plant plans | Crain's Chicago Business AbbVie buy shores up immunology business • State board takes up Advocate-Atrium deal Nov. 14 • Abbott's baby formula plant plans | Crain's Chicago Business](https://s3-prod.chicagobusiness.com/styles/1200x630/s3/AbbVieUSE_036.jpg)
AbbVie buy shores up immunology business • State board takes up Advocate-Atrium deal Nov. 14 • Abbott's baby formula plant plans | Crain's Chicago Business
![Edificio de la sede de AbbVie fachada de una compañía biofarmacéutica estadounidense que cotiza en bolsa. - Sur de San Francisco, California, EE.UU. - 2021 Fotografía de stock - Alamy Edificio de la sede de AbbVie fachada de una compañía biofarmacéutica estadounidense que cotiza en bolsa. - Sur de San Francisco, California, EE.UU. - 2021 Fotografía de stock - Alamy](https://c8.alamy.com/compes/2gc53gr/edificio-de-la-sede-de-abbvie-fachada-de-una-compania-biofarmaceutica-estadounidense-que-cotiza-en-bolsa-sur-de-san-francisco-california-ee-uu-2021-2gc53gr.jpg)